🚀 VC round data is live in beta, check it out!
Monash IVF Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Monash IVF Group and similar public comparables like Goodwill Pharma, Athens Medical Centre, Limes Schlosskliniken, MediClin and more.
Monash IVF Group Overview
About Monash IVF Group
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women’s health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
Founded
2014
HQ
Employees
889
Website
Sectors
Financials (LTM)
EV
$324M
Monash IVF Group Financials
Monash IVF Group reported last 12-month revenue of $185M and EBITDA of $42M.
In the same LTM period, Monash IVF Group generated $131M in gross profit, $42M in EBITDA, and $15M in net income.
Revenue (LTM)
Monash IVF Group P&L
In the most recent fiscal year, Monash IVF Group reported revenue of $193M and EBITDA of $45M.
Monash IVF Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $185M | XXX | $193M | XXX | XXX | XXX |
| Gross Profit | $131M | XXX | $172M | XXX | XXX | XXX |
| Gross Margin | 71% | XXX | 89% | XXX | XXX | XXX |
| EBITDA | $42M | XXX | $45M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $15M | XXX | $18M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | — | — | $63M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Monash IVF Group Stock Performance
Monash IVF Group has current market cap of $190M, and enterprise value of $324M.
Market Cap Evolution
Monash IVF Group's stock price is $0.49.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $324M | $190M | 0.6% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMonash IVF Group Valuation Multiples
Monash IVF Group trades at 1.7x EV/Revenue multiple, and 7.7x EV/EBITDA.
EV / Revenue (LTM)
Monash IVF Group Financial Valuation Multiples
As of March 19, 2026, Monash IVF Group has market cap of $190M and EV of $324M.
Equity research analysts estimate Monash IVF Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Monash IVF Group has a P/E ratio of 12.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $190M | XXX | $190M | XXX | XXX | XXX |
| EV (current) | $324M | XXX | $324M | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 7.7x | XXX | 7.3x | XXX | XXX | XXX |
| EV/EBIT | 12.6x | XXX | 10.3x | XXX | XXX | XXX |
| EV/Gross Profit | 2.5x | XXX | 1.9x | XXX | XXX | XXX |
| P/E | 12.5x | XXX | 10.7x | XXX | XXX | XXX |
| EV/FCF | 33.9x | XXX | (299.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Monash IVF Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Monash IVF Group Margins & Growth Rates
Monash IVF Group's revenue in the last 12 month grew by 5%.
Monash IVF Group's revenue per employee in the last FY averaged $0.2M.
Monash IVF Group's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Monash IVF Group's rule of X is 34% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Monash IVF Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | (7%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 34% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 36% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 73% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Monash IVF Group Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Goodwill Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| Limes Schlosskliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| MediClin | XXX | XXX | XXX | XXX | XXX | XXX |
| Concord Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Monash IVF Group M&A Activity
Monash IVF Group acquired XXX companies to date.
Last acquisition by Monash IVF Group was on XXXXXXXX, XXXXX. Monash IVF Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Monash IVF Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMonash IVF Group Investment Activity
Monash IVF Group invested in XXX companies to date.
Monash IVF Group made its latest investment on XXXXXXXX, XXXXX. Monash IVF Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Monash IVF Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Monash IVF Group
| When was Monash IVF Group founded? | Monash IVF Group was founded in 2014. |
| Where is Monash IVF Group headquartered? | Monash IVF Group is headquartered in Australia. |
| How many employees does Monash IVF Group have? | As of today, Monash IVF Group has over 889 employees. |
| Is Monash IVF Group publicly listed? | Yes, Monash IVF Group is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Monash IVF Group? | Monash IVF Group trades under MVF ticker. |
| When did Monash IVF Group go public? | Monash IVF Group went public in 2014. |
| Who are competitors of Monash IVF Group? | Monash IVF Group main competitors are Goodwill Pharma, Athens Medical Centre, Limes Schlosskliniken, MediClin. |
| What is the current market cap of Monash IVF Group? | Monash IVF Group's current market cap is $190M. |
| What is the current revenue of Monash IVF Group? | Monash IVF Group's last 12 months revenue is $185M. |
| What is the current revenue growth of Monash IVF Group? | Monash IVF Group revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Monash IVF Group? | Current revenue multiple of Monash IVF Group is 1.7x. |
| Is Monash IVF Group profitable? | Yes, Monash IVF Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Monash IVF Group? | Monash IVF Group's last 12 months EBITDA is $42M. |
| What is Monash IVF Group's EBITDA margin? | Monash IVF Group's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Monash IVF Group? | Current EBITDA multiple of Monash IVF Group is 7.7x. |
| What is the current FCF of Monash IVF Group? | Monash IVF Group's last 12 months FCF is $10M. |
| What is Monash IVF Group's FCF margin? | Monash IVF Group's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Monash IVF Group? | Current FCF multiple of Monash IVF Group is 33.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.